PennyStockSites.com

3D Eye Solutions, Inc. RightSmile, Inc. Autobytel Inc., and Chelsea Therapeutics International Ltd. Featured from Pennystocksites.com on January 28th, 2014

 

Miami, FL -- (ReleaseWire) -- 01/28/2014 -- Pennystocksites.com a leading online financial newsletter source, Reports on the following Companies: 3D Eye Solutions, Inc. (OTCMKTS:TDEY), RightSmile, Inc. (OTCMKTS:RIGH), Autobytel Inc. (NASDAQ:ABTL) and Chelsea Therapeutics International Ltd. (NASDAQ:CHTP).

Every day we scan the markets for the hottest stocks with the best potential for huge gains. Our vast network is second to none when it comes to delivering fast moving stocks and more importantly getting you out in front of them.

Join Us Here: http://pennystocksites.com/

3D Eye Solutions, Inc. (OTCMKTS:TDEY), 3D Eye Solutions, Inc. engages in developing, providing, and integrating content conversion service for the 3D stereo and auto-stereo media industry in the United States. The company offers 3D Eye Solutions conversion technology that supports education by converting older DVD video content libraries to deliver content for use. Its 3D Eye Solutions include 3D Eye Solutions auto-stereoscopic displays to enhance the viewer’s visual experience without the need for 3D glasses or special eyewear; and 3D Eye Media Module, an integrated hardware and software solution for the plug and play individuals. The company also provides auto-stereoscopic systems for high traffic venues, such as malls and shopping centers, airports, convention centers, concerts, and sport events; and corporate applications, including lobbies, conference, sales presentations, and trade show events. In addition, it offers Reality Splitter, a conversion technology process for cinema, digital signage, and home theater markets. Further, the company provides platform for content creation, management, and distribution in digital signage networks that are used in retail, education, entertainment, government, and other industries for various applications, such as retail advertising networks, corporate communications, traditional and digital billboards, digital menu boards, digital posters, cable TV, hotel lobby signage, gas pump toppers, outdoor advertising, interactive kiosks, etc. 3D Eye Solutions, Inc. was incorporated in 1992 and is based in Mount Dora, Florida.

Get a Free Technical Analysis on 3D Eye Solutions, Inc. (OTCMKTS:TDEY): http://pennystocksites.com/market-scan/?symbol=tdey

RightSmile, Inc. (OTCMKTS:RIGH), RightSmile, Inc. operates as a media marketing company in the United States and internationally. It provides commercials, HD music videos, stills, and other services. The company also distributes cosmetic teeth whitening systems and supplies to retail outlets known as SmileShoppes. It offers cosmetic teeth whitening systems to the health and beauty retailers under the RightSmile name. RightSmile, Inc. is based in Fort Lauderdale, Florida.

Get a Free Technical Analysis on RightSmile, Inc. (OTCMKTS:RIGH): http://pennystocksites.com/market-scan/?symbol=righ

Autobytel Inc. (NASDAQ:ABTL), Autobytel Inc. operates as an automotive marketing services company in the United States. It assists automotive retail dealers and manufacturers to market and sell new and used vehicles to consumers through its programs for online lead referrals, dealer marketing products and services, and online advertising programs and data products. The companys products include vehicle lead programs, including new vehicle lead program, which allows consumers to submit requests for pricing and availability of specific makes and models; and used vehicle lead program that allows consumers to search for used vehicles according to specific search parameters, such as the price, make, model, mileage, year, and location of the vehicle, as well as finance lead program that is designed to provide consumers the opportunity to obtain vehicle financing and other services from dealers or finance institutions. It owns and operates a consumer-facing automotive Website, Autobytel.com, which provides consumers the information and tools to aid them with their automotive purchase decisions; and the ability to submit inquiries requesting dealers to contact the consumers for purchasing or leasing vehicles. The companys products and services also comprise iControl by Autobytel that allows dealers various options to filter and control their vehicle leads; WebLeads+, which offers a dealer various coupon options that display marketing messages to consumers visiting the dealer's Website; Email Manager that provides follow up emails on behalf of the dealers to consumers who have submitted leads; and Lead Call, which provides a live phone call to the dealer to ensure that the dealer contacts the consumer in a timely manner. In addition, it sells fixed placement advertising across its Website and offers sponsorship opportunities to manufacturers. Autobytel Inc., formerly known as Autobytel.com Inc., was founded in 1995 and is headquartered in Irvine, California.

Get a Free Technical Analysis on Autobytel Inc. (NASDAQ:ABTL): http://pennystocksites.com/market-scan/?symbol=abtl

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP), Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products. It is primarily developing Northera (droxidopa), a therapeutic agent that is used for the treatment of symptomatic neurogenic orthostatic hypotension (Neurogenic OH) in patients with primary autonomic failure, dopamine-ß-hydroxylase, and deficiency and non-diabetic autonomic neuropathy. The company is also evaluating the potential therapeutic applications of droxidopa in reducing the frequency of falls in patients with Neurogenic OH associated with Parkinson’s disease, as well as other potentially norepinephrine-related conditions and diseases, including intradialytic hypotension, fibromyalgia, and adult attention deficit hyperactivity disorder. In addition, it engages in developing a portfolio of metabolically inert antifolates for the treatment of rheumatoid arthritis, and for the treatment of multiple other autoimmune disorders, including psoriasis, Crohn’s disease, uveitis, ankylosing spondylitis, inflammatory bowel disease, cancer, and other immunological disorders. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina.

Get a Free Technical Analysis on Chelsea Therapeutics International LTD (NASDAQ:CHTP): http://pennystocksites.com/market-scan/?symbol=chtp

Disclosure
We are not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit http://pennystocksites.com/disclaimer/ for complete risks and disclosures.

Contact:
news@pennystocksites.com
http://pennystocksites.com/
http://pennystocksites.com/disclaimer/